Rhumbline Advisers Reneo Pharmaceuticals, Inc. Transaction History
Rhumbline Advisers
- $105 Billion
- Q2 2024
A detailed history of Rhumbline Advisers transactions in Reneo Pharmaceuticals, Inc. stock. As of the latest transaction made, Rhumbline Advisers holds 983 shares of RPHM stock, worth $1,671. This represents 0.0% of its overall portfolio holdings.
Number of Shares
983
Previous 10,972
91.04%
Holding current value
$1,671
Previous $18,000
94.44%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding RPHM
# of Institutions
67Shares Held
29.3MCall Options Held
51.7KPut Options Held
0-
Nea Management Company, LLC Timonium, MD4.79MShares$8.14 Million0.68% of portfolio
-
Tang Capital Management LLC San Diego, CA3MShares$5.09 Million0.55% of portfolio
-
Highbridge Capital Management LLC New York, NY2.92MShares$4.96 Million0.94% of portfolio
-
Carlyle Group Inc. Washington, DC2.7MShares$4.59 Million0.49% of portfolio
-
Bml Capital Management, LLC Zionsville, IN2.67MShares$4.54 Million2.88% of portfolio
About Reneo Pharmaceuticals, Inc.
- Ticker RPHM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 24,479,600
- Market Cap $41.6M
- Description
- Reneo Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, focuses on the development of therapies for patients with rare genetic mitochondrial diseases. It develops REN001, a selective peroxisome proliferator-activated receptor delta agonist, which is in Phase IIb clinical trial in patients with primary mitochondrial myopathies, as w...